American Heart News - Heart News
OCTOBER 9, 2024
Research Highlights: An analysis of UK Biobank health data that included adults who had mild to severe COVID-19 before vaccines were available found an increased risk of heart attack, stroke and death among those adults during the nearly three-year.
Medical Xpress - Cardiology
OCTOBER 9, 2024
A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California.
Med Page Today
OCTOBER 9, 2024
(MedPage Today) -- A Medicare annual wellness visit (AWV) was associated with greater recognition of mild cognitive impairment in older adults, a population-based cohort study in Texas showed. Compared with those who didn't have an annual visit.
Science Daily - Heart Disease
OCTOBER 9, 2024
People with a preference for sweets are at a higher risk of developing depression, diabetes, and suffering a stroke, according to new research.
CardiacWire
OCTOBER 9, 2024
AstraZeneca expanded its cardiovascular pipeline this week, signing an exclusive license agreement for CSPC Pharmaceutical Group’s Lp(a) disruptor candidate, YS2302018. The deal comes with a $100M upfront investment that could reach $1.92B depending on further milestones. YS2302018 is a small molecule Lipoprotein (a) disruptor intended to treat dyslipidemia patients by preventing the formation of excess blood lipids.
Science Daily - Heart Disease
OCTOBER 9, 2024
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heart attack, stroke and death from any cause for up to three years for people with and without cardiovascular disease, according to new research.
Medical Xpress - Cardiology
OCTOBER 9, 2024
Researchers from the Faculty of Medicine and Health Technology (MET) at Tampere University have successfully created a cell culture platform that allows two cultivated vascular networks to interconnect. The blood vessels in these networks are equivalent to human capillaries in size and structure, facilitating the study of human capillary networks in a laboratory setting.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Med Page Today
OCTOBER 9, 2024
(MedPage Today) -- A nonselective extracorporeal blood purification (EBP) device connected to the cardiopulmonary bypass circuit during surgery reduced the risk of cardiac surgery-associated acute kidney injury (CSA-AKI), a randomized trial found.
Science Daily - Heart Disease
OCTOBER 9, 2024
Researchers find cardiac arrhythmias in partygoers who had drunk a lot of alcohol.
Med Page Today
OCTOBER 9, 2024
(MedPage Today) -- Ahead of an FDA advisory committee meeting on Thursday, agency reviewers cast doubt on the efficacy of elamipretide for Barth syndrome, an ultra-rare disease that has no approved treatments. In its new drug application, Stealth.
HCPLive
OCTOBER 9, 2024
Optimal use of GDMT therapy in heart failure could save an estimated 1.19 million lives globally over the course of 1 year.
European Journal of Heart Failure
OCTOBER 9, 2024
Cardiovascular outcomes with exenatide in type 2 diabetes (T2D) according to left ventricular ejection fraction (LVEF): the EXSCEL trial. CI, confidence interval; CVD, cardiovascular disease; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HHF, hospitalization for heart failure; HR, hazard ratio; NYHA, New York Heart Association. Aims Glucagon-like peptide-1 receptor agonists reduce major adverse cardiovascular events (MACE) and cardiovascular mortality in people with type 2 diabetes (T2D).
NEJM Journal Watch - Cardiology
OCTOBER 9, 2024
After adjustment for known risk factors, ICAD was associated with elevated dementia risk at 5 years.
Physiologically Speaking
OCTOBER 9, 2024
Researchers claim to have discovered “exercise in a pill” every few years, like clockwork. They then proceed to oversell its benefits and potential applications to human health and disease. Inevitably the media becomes fascinated with this new molecule or pill and runs wild with headlines about how we have found a way to mimic exercise without all of the hard work (finally).
Science Daily - Heart Disease
OCTOBER 9, 2024
Researchers have developed a groundbreaking cell culture platform that enables the formation of two distinct but interconnected vascular networks. Their breakthrough holds tremendous promise for advancing biomedical research. Organ-on-chips are microfluidic cell cultures that replicate human physiology, significantly reducing the costs of drug development, minimizing the need for animal testing and enabling personalized treatment.
American College of Cardiology
OCTOBER 9, 2024
Does the “weekend warrior†pattern of physical activity yield similar reduction in risk for disease as spreading the physical activity across a week?
HCPLive
OCTOBER 9, 2024
During situations in which those with severe allergies suffer from fatal anaphylaxis, adrenaline autoinjectors were shown in this study to have little effect on such reactions.
American College of Cardiology
OCTOBER 9, 2024
Renal denervation (RDN) is an adjunct treatment for hypertension (HTN) that involves catheter ablation of the sympathetic plexus in the adventitia of the renal arteries using radiofrequency (RF) or ultrasound waves.
HCPLive
OCTOBER 9, 2024
New research reveals amyl nitrite (poppers) use is linked to dermatitis, with perianal and perioral regions most affected.
American College of Cardiology
OCTOBER 9, 2024
What is the value of specific biomarkers for heart failure (HF) risk stratification in patients with atrial fibrillation (AF)?
HCPLive
OCTOBER 9, 2024
Younossi explains how MASH negatively impacts patients’ quality of life and describes resmetirom’s benefit across multiple HRQoL domains.
Medical Xpress - Cardiology
OCTOBER 9, 2024
Medicine is subjecting the negative effects of alcohol on body and health to ever greater scrutiny. This should not surprise us, as alcohol is one of the strongest cell toxins that exist. In a recent study, doctors at LMU University Hospital took mobile ECG monitors along to parties of young people who had one principal aim: to drink and be merry.
HCPLive
OCTOBER 9, 2024
Remission according to the simplified definition correlated with the 2016 preliminary gout remission definition and GIS score improvements.
Becker's Hospital Review - Cardiology
OCTOBER 9, 2024
Renton, Wash.-based Providence Heart Institute's new Howard "H" White Center for Cardiac Amyloidosis has received a $1 million donation from former NBA star Michael Jordan.
HCPLive
OCTOBER 9, 2024
A comprehensive model of clinical and radiomic features was more accurate in distinguishing flares than either model alone.
American College of Cardiology
OCTOBER 9, 2024
In this week’s View, Dr. Eagle looks at cardiovascular events following COVID vaccination in adults.
HCPLive
OCTOBER 9, 2024
Saggese explains the importance of second-line therapies in PBC, newly approved treatment options, and their impact on treatment goals and timelines.
American College of Cardiology
OCTOBER 9, 2024
What are the outcomes of bivalirudin vs. heparin anticoagulation during percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI)?
HCPLive
OCTOBER 9, 2024
Topline results from the Phase 2b ODYSSEY trial show suprachoroidal CLS-AX achieved all primary and secondary outcomes for wet AMD.
Journal of Cardiothoracic Surgery
OCTOBER 9, 2024
To investigate whether feature tracking cardiac magnetic resonance (FT-CMR) can identify subclinical myocardial dysfunction in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA).
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
AimOne of the philosophies of minimally invasive mitral surgery is to enhance recovery after surgery (ERAS). Beyond surgical applications, ERAS applications provide a complementary approach to optimize postoperative course and discharge. In this report, we aim to present institutional protocol for ERAS and its results in patients who underwent totally endoscopic mitral valve surgery (TEMVS).Patients and methodsBetween 2021 and 2023, totally 113 patients who underwent TEMVS were included in this
Medical Xpress - Cardiology
OCTOBER 9, 2024
There are more than 65 million Hispanic and Latino people living in the U.S.—the second-largest racial or ethnic minority population in the country. Yet when it comes to heart and brain health, less may be understood about this population than any other.
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
ObjectivesThe discovery of pluripotent stem cell-derived cardiomyocytes (PSC-CMs) has not only deepened our understanding of the pathogenesis and progression of heart disease, but also advanced the development of engineered cardiac tissues, cardiac regenerative therapy, drug discovery and the cardiotoxicity assessment of drugs. This study aims to visualize the developmental trajectory of PSC-CM research over the past 18 years to identify the emerging research frontiers and challenges.MethodsThe
HCPLive
OCTOBER 9, 2024
A meta-analysis shows that wet cupping reduces migraine intensity but doesn't improve quality of life. Adjunctive therapies offer limited additional benefits.
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
BackgroundCorrected QT (QTc) is an important electrocardiographic (ECG) interval. Physicians rely on automated QTc provided by ECG machines while the manual method is the recommended method. We sought to assess the prevalence and predictors of false positive QTc prolongation by the automated measurement.Methods and resultsConsecutive ECGs were retrieved from the ECG database at King Khaled University Hospital.
HCPLive
OCTOBER 9, 2024
These findings highlight the underrepresentation of Black and Hispanic food allergy clinical trial participants and raise concerns about the generalizability of clinical research findings.
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
BackgroundTraditional prognostic models for ST-segment elevation myocardial infarction (STEMI) have limitations in statistical methods and usability.ObjectiveWe aimed to develop a machine-learning (ML) based risk score to predict in-hospital mortality, intensive care unit (ICU) admission, and left ventricular ejection fraction less than 40% (LVEF < 40%) in STEMI patients.MethodsWe reviewed 1,863 consecutive STEMI patients undergoing primary percutaneous coronary intervention (pPCI) or rescue PCI
Expert insights. Personalized for you.
145 
Let's personalize your content